# Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders

> **NCT02748798** · EARLY_PHASE1 · TERMINATED · sponsor: **Thunder Bay Regional Health Research Institute** · enrollment: 10 (actual)

## Conditions studied

- Lung Transplant
- Lung Resection
- Lung Cancer
- Asthma
- Cystic Fibrosis
- Chronic Obstructive Pulmonary Disease
- Emphysema
- Mesothelioma
- Asbestosis
- Pulmonary Embolism
- Interstitial Lung Disease
- Pulmonary Fibrosis
- Bronchiectasis
- Seasonal Allergies
- Cold Virus
- Lung Infection
- Pulmonary Hypertension
- Pulmonary Dysplasia
- Obstructive Sleep Apnea

## Interventions

- **DRUG:** HP 3He
- **DRUG:** HP 129Xe
- **DRUG:** PFP
- **DRUG:** SF6
- **DEVICE:** 129Xe Small and Large Human Lung Coil
- **DEVICE:** 3He Human Lung Coil
- **DEVICE:** PFP and SF6 Human Lung Coil

## Key facts

- **NCT ID:** NCT02748798
- **Lead sponsor:** Thunder Bay Regional Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-11-10
- **Primary completion:** 2021-10-16
- **Final completion:** 2021-10-16
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Funding is no longer available due to the failure to enroll the target number of participants within the required timeframe.
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02748798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02748798, "Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02748798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*